Please ensure Javascript is enabled for purposes of website accessibility

Why Invitae Stock Fell Today

By Keith Speights - Updated Mar 3, 2021 at 3:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The medical genetics company was pulled down by a broader sell-off of growth stocks.

What happened

Shares of Invitae (NVTA 14.86%) had fallen 6.6% as of 3:13 p.m. EST on Wednesday. The medical genetics company didn't announce any news that would cause the stock to drop. Instead, Invitae's decline today appears to be part of a broader sell-off of high-growth stocks, with the Nasdaq Composite Index falling 2%.

So what

The best thing that investors can do on days like today is...nothing. Growth stocks like Invitae that trade at premium valuations tend to be highly volatile. Solid business execution combined with great long-term prospects, however, outweigh short-term volatility.

DNA with an image of a head and 1s and 0s in the background

Image source: Getty Images.

Invitae continues to execute well. The company posted year-over-year revenue growth of 51% in the fourth quarter, thanks in large part to its acquisition of ArcherDX. This result beat the Wall Street consensus estimate.

The medical genetics company's growth prospects also are significant. Invitae projects that its total addressable market for genetic testing tops $150 billion. It thinks that the market for genetic testing in older individuals, including cancer screening and therapy selection, is especially promising. 

Now what

Invitae expects to generate annual revenue growth of 50% to 60% over the next few years. If the company can achieve this level of growth, today's drop will only be a blip in an overall upward trend.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Invitae Stock Quote
Invitae
NVTA
$4.02 (14.86%) $0.52

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
356%
 
S&P 500 Returns
124%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.